Glutaryl-CoA Dehydrogenase Deficiency
Oncology·MeSH: Hermanski-Pudlak Syndrome
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Glutaryl-CoA Dehydrogenase Deficiency?
There are 1 clinical trial targeting Glutaryl-CoA Dehydrogenase Deficiency tracked by BioSniper.
What is the prevalence of Glutaryl-CoA Dehydrogenase Deficiency?
The estimated prevalence of Glutaryl-CoA Dehydrogenase Deficiency is approximately 5.0 per 100,000 population.
Deep-dive into Glutaryl-CoA Dehydrogenase Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis